HEK293T cells, PK-15 cells, and BHK-21 cells were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). Stable PK-15 cells ectopically expressing PRV UL13 (UL13-PK-15 cells), along with control cells, were generated previously [24]. Cells were maintained in Dulbecco’s minimal essential medium (DMEM) (Gibco, New York, NY, USA) containing 10% fetal bovine serum (FBS) (Biological Industries, Israel) and 1% penicillin–streptomycin (Gibco, New York, NY, USA) at 37 °C in 5% CO2. All cells tested negative for mycoplasma using a mycoplasma detection kit (TransGen Biotech, Beijing, China). PRV (Bartha-K61 strain) was purchased from the China Veterinary Culture Collection Center (Cat# CVCC AV249, Beijing, China), and was purified in BHK-21 cells. The PRV-∆UL13 recombinant strain was generated previously [24]. The wild-type PRV (PRV-WT) and PRV-∆UL13 PRV strains were amplified and titrated in PK-15 cells using standard protocols. Sendai virus (SeV), described previously [26], was propagated in 10-day-old embryonated eggs. SeV titers were then determined via the Reed–Muench method using MDCK cells.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.